{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T04:03:49Z","timestamp":1778126629565,"version":"3.51.4"},"reference-count":68,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1053\/j.seminhematol.2023.03.007","type":"journal-article","created":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T22:45:50Z","timestamp":1680734750000},"page":"90-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Report of Consensus Panel 3 from the 11th International workshop on Waldenstr\u00f6m's Macroglobulinemia: Recommendations for molecular diagnosis in Waldenstr\u00f6m's Macroglobulinemia"],"prefix":"10.1053","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4120-2787","authenticated-orcid":false,"given":"Ram\u00f3n","family":"Garcia-Sanz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marzia","family":"Varettoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Ferrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Poulain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesus F.","family":"San-Miguel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria L.","family":"Guerrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Drandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tina","family":"Bagratuni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"McMaster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aldo M.","family":"Roccaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damien","family":"Roos-Weil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merav","family":"Leiba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Fernandez","family":"De Larrea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge J.","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Dimopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.G.","family":"Owen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.P.","family":"Treon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.R.","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1053\/j.seminhematol.2023.03.007_bib0001","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1182\/blood.2022015851","article-title":"The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2023.03.007_bib0002","article-title":"Diagnostics in Waldenstr\u00f6m's macroglobulinemia: a consensus statement of the European Consortium for Waldenstr\u00f6m's Macroglobulinemia","author":"Dogliotti","year":"2022","journal-title":"Leukemia"},{"issue":"11","key":"10.1053\/j.seminhematol.2023.03.007_bib0003","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1200\/JCO.19.02314","article-title":"Genomic landscape of Waldenstr\u00f6m Macroglobulinemia and its impact on treatment strategies","volume":"38","author":"Treon","year":"2020","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1053\/j.seminhematol.2023.03.007_bib0004","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1158\/0008-5472.CAN-08-3701","article-title":"Identification of copy number abnormalities and inactivating mutations in two negative regulators of nuclear factor-kappaB signaling pathways in Waldenstrom's macroglobulinemia","volume":"69","author":"Braggio","year":"2009","journal-title":"Cancer Res"},{"issue":"4","key":"10.1053\/j.seminhematol.2023.03.007_bib0005","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1309\/6U88-357U-UKJ5-YPT3","article-title":"Cytogenetic findings in lymphoplasmacytic lymphoma\/Waldenstr\u00f6m macroglobulinemia. Chromosomal abnormalities are associated with the polymorphous subtype and an aggressive clinical course","volume":"116","author":"Mansoor","year":"2001","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"10.1053\/j.seminhematol.2023.03.007_bib0006","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3816\/CLM.2005.n.007","article-title":"Immunophenotypic and cytogenetic comparison of Waldenstrom's macroglobulinemia with splenic marginal zone lymphoma","volume":"5","author":"Ocio","year":"2005","journal-title":"Clin Lymphoma"},{"issue":"9","key":"10.1053\/j.seminhematol.2023.03.007_bib0007","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1038\/sj.leu.2404314","article-title":"Trisomy 4, a new chromosomal abnormality in Waldenstr\u00f6m's macroglobulinemia: a study of 39 cases","volume":"20","author":"Terr\u00e9","year":"2006","journal-title":"Leukemia"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.03.007_bib0008","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3816\/CLM.2009.n.009","article-title":"High-resolution genomic analysis in Waldenstr\u00f6m's macroglobulinemia identifies disease-specific and common abnormalities with marginal zone lymphomas","volume":"9","author":"Braggio","year":"2009","journal-title":"Clin Lymphoma Myeloma"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.03.007_bib0009","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3816\/CLML.2011.n.021","article-title":"High-throughput genomic analysis in Waldenstr\u00f6m's macroglobulinemia","volume":"11","author":"Poulain","year":"2011","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"11","key":"10.1053\/j.seminhematol.2023.03.007_bib0010","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/ajh.23545","article-title":"Genome wide SNP array identified multiple mechanisms of genetic changes in Waldenstrom macroglobulinemia","volume":"88","author":"Poulain","year":"2013","journal-title":"Am J Hematol"},{"issue":"4","key":"10.1053\/j.seminhematol.2023.03.007_bib0011","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3324\/haematol.2012.070458","article-title":"Chromosomal aberrations and their prognostic value in a series of 174 untreated patients with Waldenstr\u00f6m's macroglobulinemia","volume":"98","author":"Nguyen-Khac","year":"2013","journal-title":"Haematologica"},{"issue":"12","key":"10.1053\/j.seminhematol.2023.03.007_bib0012","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/ajh.26339","article-title":"Cytogenetic and molecular abnormalities in Waldenstr\u00f6m's macroglobulinemia patients: Correlations and prognostic impact","volume":"96","author":"Krzisch","year":"2021","journal-title":"Am J Hematol"},{"issue":"5","key":"10.1053\/j.seminhematol.2023.03.007_bib0013","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/bjh.17028","article-title":"6q deletion in Waldenstrom macroglobulinaemia negatively affects time to transformation and survival","volume":"192","author":"Garcia-Sanz","year":"2021","journal-title":"British Journal of Haematology"},{"issue":"4","key":"10.1053\/j.seminhematol.2023.03.007_bib0014","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3816\/CLM.2005.n.009","article-title":"Cell cycle analysis of Waldenstrom's macroglobulinemia","volume":"5","author":"Ocio","year":"2005","journal-title":"Clin Lymphoma"},{"issue":"2","key":"10.1053\/j.seminhematol.2023.03.007_bib0015","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.cancergencyto.2006.04.009","article-title":"6q deletion discriminates Waldenstr\u00f6m macroglobulinemia from IgM monoclonal gammopathy of undetermined significance","volume":"169","author":"Schop","year":"2006","journal-title":"Cancer Genet Cytogenet"},{"issue":"20","key":"10.1053\/j.seminhematol.2023.03.007_bib0016","doi-asserted-by":"crossref","first-page":"6325","DOI":"10.1158\/1078-0432.CCR-17-0007","article-title":"TP53 mutation and its prognostic significance in Waldenstrom's macroglobulinemia","volume":"23","author":"Poulain","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1053\/j.seminhematol.2023.03.007_bib0017","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/bjh.15560","article-title":"TP53 mutations are associated with mutated MYD88 and CXCR4, and confer an adverse outcome in Waldenstr\u00f6m macroglobulinaemia","volume":"184","author":"Gustine","year":"2019","journal-title":"Br J Haematol"},{"issue":"12","key":"10.1053\/j.seminhematol.2023.03.007_bib0018","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.3324\/haematol.2017.172718","article-title":"Pattern of somatic mutations in patients with Waldenstr\u00f6m macroglobulinemia or IgM monoclonal gammopathy of undetermined significance","volume":"102","author":"Varettoni","year":"2017","journal-title":"Haematologica"},{"issue":"9","key":"10.1053\/j.seminhematol.2023.03.007_bib0019","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1056\/NEJMoa1200710","article-title":"MYD88 L265P somatic mutation in Waldenstr\u00f6m's macroglobulinemia","volume":"367","author":"Treon","year":"2012","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1053\/j.seminhematol.2023.03.007_bib0020","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1182\/blood-2012-09-454355","article-title":"MYD88 L265P in Waldenstr\u00f6m macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction","volume":"121","author":"Xu","year":"2013","journal-title":"Blood"},{"issue":"13","key":"10.1053\/j.seminhematol.2023.03.007_bib0021","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1182\/blood-2012-09-457101","article-title":"Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasms","volume":"121","author":"Varettoni","year":"2013","journal-title":"Blood"},{"issue":"8","key":"10.1053\/j.seminhematol.2023.03.007_bib0022","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1038\/leu.2013.62","article-title":"MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenstr\u00f6m's macroglobulinemia","volume":"27","author":"Jim\u00e9nez","year":"2013","journal-title":"Leukemia"},{"issue":"2","key":"10.1053\/j.seminhematol.2023.03.007_bib0023","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/bjh.18502","article-title":"Prognostic impact of MYD88 and CXCR4 mutations assessed by droplet digital polymerase chain reaction in IgM monoclonal gammopathy of undetermined significance and smouldering Waldenstr\u00f6m macroglobulinaemia","volume":"200","author":"Moreno","year":"2023","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1053\/j.seminhematol.2023.03.007_bib0024","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3324\/haematol.2017.186528","article-title":"Highly sensitive MYD88(L265P) mutation detection by droplet digital polymerase chain reaction in Waldenstrom macroglobulinemia","volume":"103","author":"Drandi","year":"2018","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2023.03.007_bib0025","unstructured":"Ferrante MD, D Zibellini, S Marcheselli, et al. Non-invasive screening of MYD88 L265P mutation by droplet digital PCR in IgM-gammopathies: results of the multicentric \u201cBIOWM\u201d trial of the Fondazione Italiana Linfomi (FIL). 11th International Workshop on Waldenstr\u00f6m's Macroglobulinemia. Madrid, Spain; 2022:Abstract #13."},{"issue":"1","key":"10.1053\/j.seminhematol.2023.03.007_bib0026","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1182\/bloodadvances.2021005354","article-title":"Determination of MYD88L265P mutation fraction in IgM monoclonal gammopathies","volume":"6","author":"Bagratuni","year":"2022","journal-title":"Blood Adv"},{"issue":"6","key":"10.1053\/j.seminhematol.2023.03.007_bib0027","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/bjh.12313","article-title":"Improved accuracy of discrimination between IgM multiple myeloma and Waldenstr\u00f6m macroglobulinaemia by testing for MYD88 L265P mutations","volume":"161","author":"Willenbacher","year":"2013","journal-title":"Br J Haematol"},{"issue":"24","key":"10.1053\/j.seminhematol.2023.03.007_bib0028","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1182\/blood-2013-12-543306","article-title":"Mutations in TLR\/MYD88 pathway identify a subset of young chronic lymphocytic leukemia patients with favorable outcome","volume":"123","author":"Mart\u00ednez-Trillos","year":"2014","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.03.007_bib0029","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/leu.2012.257","article-title":"IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenstr\u00f6m macroglobulinemia\/lymphoplasmacytic lymphomas","volume":"27","author":"Gachard","year":"2013","journal-title":"Leukemia"},{"issue":"2","key":"10.1053\/j.seminhematol.2023.03.007_bib0030","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41375-022-01802-y","article-title":"Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY","volume":"37","author":"Mansouri","year":"2023","journal-title":"Leukemia"},{"issue":"6","key":"10.1053\/j.seminhematol.2023.03.007_bib0031","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMc1506192","article-title":"MYD88 mutations and response to ibrutinib in Waldenstr\u00f6m's Macroglobulinemia","volume":"373","author":"Treon","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2023.03.007_bib0032","series-title":"IWWM ed. 11th International Workshop on Waldenstr\u00f6m's Macroglobulinemia","article-title":"Genomic studies in WM: first results from the BIOWM study of Fondazione Italiana Linfomi (FIL)","author":"Varettoni","year":"2022"},{"issue":"11","key":"10.1053\/j.seminhematol.2023.03.007_bib0033","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1182\/blood-2013-09-525808","article-title":"The genomic landscape of Waldenstrom macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis","volume":"123","author":"Hunter","year":"2014","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.seminhematol.2023.03.007_bib0034","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00277-017-3207-3","article-title":"Unraveling the heterogeneity of IgM monoclonal gammopathies: a gene mutational and gene expression study","volume":"97","author":"Jim\u00e9nez","year":"2018","journal-title":"Ann Hematol"},{"key":"10.1053\/j.seminhematol.2023.03.007_bib0035","series-title":"11th International Workshop of Waldenstrom Macroglobulinemia","article-title":"ASPEN biomarker analysis: response to Bruton Tyrosine Kinase Inhibitor (BTKi) treatment in patients with Waldenstr\u00f6m Macroglobulinemia (WM) harboring CXCR4, TP53, and TERT mutations","author":"Dimopoulos","year":"2022"},{"issue":"26","key":"10.1053\/j.seminhematol.2023.03.007_bib0036","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1182\/blood-2014-03-564583","article-title":"C1013G\/CXCR4 acts as a driver mutation of tumor progression and modulator of drug resistance in lymphoplasmacytic lymphoma","volume":"123","author":"Roccaro","year":"2014","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.03.007_bib0037","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/leu.2014.187","article-title":"The WHIM-like CXCR4(S338X) somatic mutation activates AKT and ERK, and promotes resistance to ibrutinib and other agents used in the treatment of Waldenstrom's Macroglobulinemia","volume":"29","author":"Cao","year":"2015","journal-title":"Leukemia"},{"issue":"2","key":"10.1053\/j.seminhematol.2023.03.007_bib0038","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41375-020-01102-3","article-title":"CXCR4 in Waldenstr\u00f6m's Macroglobulinema: chances and challenges","volume":"35","author":"Kaiser","year":"2021","journal-title":"Leukemia"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.03.007_bib0039","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1182\/blood-2011-12-395608","article-title":"WHIM syndrome caused by a single amino acid substitution in the carboxy-tail of chemokine receptor CXCR4","volume":"120","author":"Liu","year":"2012","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.seminhematol.2023.03.007_bib0040","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1182\/bloodadvances.2021006106","article-title":"Response and survival predictors in a cohort of 319 patients with Waldenstr\u00f6m macroglobulinemia treated with ibrutinib monotherapy","volume":"6","author":"Castillo","year":"2022","journal-title":"Blood Adv"},{"issue":"9","key":"10.1053\/j.seminhematol.2023.03.007_bib0041","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1200\/JCO.2016.71.0814","article-title":"Genomics, signaling, and treatment of Waldenstr\u00f6m Macroglobulinemia","volume":"35","author":"Hunter","year":"2017","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1053\/j.seminhematol.2023.03.007_bib0042","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1002\/ajh.25600","article-title":"Clinical and molecular characteristics of lymphoplasmacytic lymphoma not associated with an IgM monoclonal protein: a multicentric study of the Rete Ematologica Lombarda (REL) network","volume":"94","author":"Varettoni","year":"2019","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1053\/j.seminhematol.2023.03.007_bib0043","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1158\/1078-0432.CCR-15-0646","article-title":"Genomic landscape of CXCR4 mutations in Waldenstr\u00f6m Macroglobulinemia","volume":"22","author":"Poulain","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"8","key":"10.1053\/j.seminhematol.2023.03.007_bib0044","doi-asserted-by":"crossref","first-page":"e591","DOI":"10.1038\/bcj.2017.72","article-title":"From Waldenstr\u00f6m's macroglobulinemia to aggressive diffuse large B-cell lymphoma: a whole-exome analysis of abnormalities leading to transformation","volume":"7","author":"Jim\u00e9nez","year":"2017","journal-title":"Blood Cancer J"},{"issue":"2","key":"10.1053\/j.seminhematol.2023.03.007_bib0045","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/sonc.2003.50082","article-title":"Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia","volume":"30","author":"Owen","year":"2003","journal-title":"Semin Oncol"},{"issue":"5","key":"10.1053\/j.seminhematol.2023.03.007_bib0046","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/PAS.0000000000000411","article-title":"MYD88 (L265P) somatic mutation in marginal zone B-cell lymphoma","volume":"39","author":"Martinez-Lopez","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1053\/j.seminhematol.2023.03.007_bib0047","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1158\/0008-5472.CAN-18-0215","article-title":"L265P mutation in lymphoid malignancies","volume":"78","author":"Yu","year":"2018","journal-title":"Cancer Res"},{"issue":"10","key":"10.1053\/j.seminhematol.2023.03.007_bib0048","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1038\/leu.2013.166","article-title":"A multiparameter flow cytometry immunophenotypic algorithm for the identification of newly diagnosed symptomatic myeloma with an MGUS-like signature and long-term disease control","volume":"27","author":"Paiva","year":"2013","journal-title":"Leukemia"},{"issue":"8","key":"10.1053\/j.seminhematol.2023.03.007_bib0049","doi-asserted-by":"crossref","first-page":"e624","DOI":"10.1097\/HS9.0000000000000624","article-title":"Diagnostic next-generation sequencing frequently fails to detect MYD88","volume":"5","author":"Kofides","year":"2021","journal-title":"Hemasphere"},{"issue":"4","key":"10.1053\/j.seminhematol.2023.03.007_bib0050","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/bjh.17385","article-title":"Bone marrow involvement and subclonal diversity impairs detection of mutated CXCR4 by diagnostic next-generation sequencing in Waldenstr\u00f6m macroglobulinaemia","volume":"194","author":"Gustine","year":"2021","journal-title":"Br J Haematol"},{"issue":"7939","key":"10.1053\/j.seminhematol.2023.03.007_bib0051","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41586-022-05448-9","article-title":"Common and rare variant associations with clonal haematopoiesis phenotypes","volume":"612","author":"Kessler","year":"2022","journal-title":"Nature"},{"issue":"26","key":"10.1053\/j.seminhematol.2023.03.007_bib0052","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","article-title":"Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence","volume":"371","author":"Genovese","year":"2014","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.03.007_bib0053","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1365-2141.2006.06389.x","article-title":"6q deletion in Waldenstrom macroglobulinemia is associated with features of adverse prognosis","volume":"136","author":"Ocio","year":"2007","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1053\/j.seminhematol.2023.03.007_bib0054","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1053\/sonc.2003.50075","article-title":"Genetics and cytogenetics of Waldenstrom's macroglobulinemia","volume":"30","author":"Schop","year":"2003","journal-title":"Semin Oncol"},{"issue":"11","key":"10.1053\/j.seminhematol.2023.03.007_bib0055","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.3324\/haematol.2022.281053","article-title":"Inflammation in Waldenstr\u00f6m macroglobulinemia is associated with 6q deletion and need for treatment initiation","volume":"107","author":"Forgeard","year":"2022","journal-title":"Haematologica"},{"issue":"3","key":"10.1053\/j.seminhematol.2023.03.007_bib0056","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa1709974","article-title":"Long-term follow-up of monoclonal gammopathy of undetermined significance","volume":"378","author":"Kyle","year":"2018","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1053\/j.seminhematol.2023.03.007_bib0057","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.3390\/ijms17122003","article-title":"Molecular mechanisms of p53 deregulation in cancer: an overview in multiple myeloma","volume":"17","author":"Herrero","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1053\/j.seminhematol.2023.03.007_bib0058","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1136\/jclinpath-2018-205622","article-title":"Relevance of TP53 for CLL diagnostics","volume":"72","author":"Catherwood","year":"2019","journal-title":"J Clin Pathol"},{"issue":"21","key":"10.1053\/j.seminhematol.2023.03.007_bib0059","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1182\/bloodadvances.2018022962","article-title":"Insights into the genomic landscape of MYD88 wild-type Waldenstr\u00f6m macroglobulinemia","volume":"2","author":"Hunter","year":"2018","journal-title":"Blood Adv"},{"issue":"5","key":"10.1053\/j.seminhematol.2023.03.007_bib0060","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3390\/diagnostics11050779","article-title":"MYD88L265P detection in IgM monoclonal gammopathies: methodological considerations for routine implementation","volume":"11","author":"Ferrante","year":"2021","journal-title":"Diagnostics (Basel)"},{"issue":"9","key":"10.1053\/j.seminhematol.2023.03.007_bib0061","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1038\/bcj.2013.28","article-title":"High prevalence of oncogenic MYD88 and CD79B mutations in diffuse large B-cell lymphomas presenting at immune-privileged sites","volume":"3","author":"Kraan","year":"2013","journal-title":"Blood Cancer J"},{"issue":"10","key":"10.1053\/j.seminhematol.2023.03.007_bib0062","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1097\/PAI.0000000000000020","article-title":"Detection of MYD88 L265P mutation by real-time allele-specific oligonucleotide polymerase chain reaction","volume":"22","author":"Jimenez","year":"2014","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.03.007_bib0063","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/bjh.15792","article-title":"Digital PCR in bone marrow trephine biopsies is highly sensitive for MYD88","volume":"186","author":"Willenbacher","year":"2019","journal-title":"Br J Haematol"},{"issue":"10","key":"10.1053\/j.seminhematol.2023.03.007_bib0064","doi-asserted-by":"crossref","first-page":"5570","DOI":"10.3390\/ijms23105570","article-title":"MYD88 mutations: transforming the landscape of IgM monoclonal gammopathies","volume":"23","author":"Alcoceba","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1053\/j.seminhematol.2023.03.007_bib0065","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/bjh.16088","article-title":"CXCR4 mutation subtypes impact response and survival outcomes in patients with Waldenstr\u00f6m macroglobulinaemia treated with ibrutinib","volume":"187","author":"Castillo","year":"2019","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1053\/j.seminhematol.2023.03.007_bib0066","doi-asserted-by":"crossref","first-page":"E312","DOI":"10.1002\/ajh.24366","article-title":"Atrial fibrillation associated with ibrutinib in Waldenstr\u00f6m macroglobulinemia","volume":"91","author":"Gustine","year":"2016","journal-title":"Am J Hematol"},{"issue":"5","key":"10.1053\/j.seminhematol.2023.03.007_bib0067","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/bjh.13897","article-title":"Clonal architecture of CXCR4 WHIM-like mutations in Waldenstr\u00f6m Macroglobulinaemia","volume":"172","author":"Xu","year":"2016","journal-title":"Br J Haematol"},{"issue":"19","key":"10.1053\/j.seminhematol.2023.03.007_bib0068","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1182\/bloodadvances.2019000635","article-title":"CXCR4WHIM clonality is an important determinant of ibrutinib outcomes in patients with Waldenstr\u00f6m macroglobulinemia","volume":"3","author":"Gustine","year":"2019","journal-title":"Blood Adv"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196323000276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196323000276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:29:15Z","timestamp":1758522555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196323000276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0037196323000276"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2023.03.007","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Report of Consensus Panel 3 from the 11th International workshop on Waldenstr\u00f6m's Macroglobulinemia: Recommendations for molecular diagnosis in Waldenstr\u00f6m's Macroglobulinemia","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2023.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}